THOMAS DETRE, M.D.; T. TERRY HAYASHI, M.D.; DAVID F. ARCHER, M.D.
DETRE T, HAYASHI TT, ARCHER DF. Drugs Spotlight Program: Management of the Menopause. Ann Intern Med. 1978;88:373-378. doi: 10.7326/0003-4819-88-3-373
Download citation file:
Published: Ann Intern Med. 1978;88(3):373-378.
Menopause is merely a clinically discernible clue symbolic of the multitude of changes preceding or following the cessation of menses by many years. Because of the time span involved, separating changes observed in the menopausal transition from other age-related maturational events presents serious methodologic problems. Of the host of psychologic and psychosomatic symptoms, only hot flushes and associated sweats occur more frequently in this epoch, while an interplay between hormonal and age-related effects is assumed in atrophic changes involving the genitourinary organs. The relation between menopause and osteoporosis is suggestive but by no means proven, as is the risk for cardiovascular disease. Empiric evidence points to the usefulness of estrogen for the management of vasomotor instability, the symptoms associated with atrophy of the genitourinary tract, and in the prophylaxis of osteoporosis, but not in the treatment of anxiety, depression, and other psychiatric disorders.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Endocrine and Metabolism, Hematology/Oncology, Metabolic Bone Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only